These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22820131)

  • 21. Specific CD8⁺ T cells recognize human herpesvirus 6B.
    Martin LK; Schub A; Dillinger S; Moosmann A
    Eur J Immunol; 2012 Nov; 42(11):2901-12. PubMed ID: 22886850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG; Jakubowski A; Jaffe D; Sepkowitz K; Pamer E; O'Reilly RJ; Papanicolaou GA
    Transpl Infect Dis; 2007 Dec; 9(4):286-94. PubMed ID: 17511819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High level of perforin expression in T cells: An early prognostic marker of the severity of herpesvirus reactivation after allogeneic stem cell transplantation in adults.
    Pietersma FL; van Dorp S; Jacobi R; Ran L; Nanlohy NM; Schuurman R; Minnema MC; Meijer E; van Baarle D
    Clin Infect Dis; 2010 Mar; 50(5):717-25. PubMed ID: 20121571
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.
    Nakayama H; Yamazaki R; Kato J; Koda Y; Sakurai M; Abe R; Watanuki S; Sumiya C; Shiroshita K; Fujita S; Yamaguchi K; Okamoto S; Mori T
    J Infect Dis; 2019 Aug; 220(6):1001-1007. PubMed ID: 31063196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. "Cytomegalovirus disease" in renal allograft recipients: is human herpesvirus 7 a co-factor for disease progression?
    Osman HK; Peiris JS; Taylor CE; Warwicker P; Jarrett RF; Madeley CR
    J Med Virol; 1996 Apr; 48(4):295-301. PubMed ID: 8699160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of human herpes virus 6 infections with a quantitative, standardized, commercial kit in pediatric stem cell transplant recipients after transplantation.
    Mutlu D; Uygun V; Yazisiz H; Tezcan G; Hazar V; Colak D
    Ann Saudi Med; 2014; 34(1):6-11. PubMed ID: 24658548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human herpes virus 6 and multiple sclerosis: a Finnish twin study.
    Kuusisto H; Hyöty H; Kares S; Kinnunen E; Elovaara I
    Mult Scler; 2008 Jan; 14(1):54-8. PubMed ID: 17893113
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The complex relationship between human herpesvirus 6 and acute graft-versus-host disease.
    Pichereau C; Desseaux K; Janin A; Scieux C; Peffault de Latour R; Xhaard A; Robin M; Ribaud P; Agbalika F; Chevret S; Socié G
    Biol Blood Marrow Transplant; 2012 Jan; 18(1):141-4. PubMed ID: 21801705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
    Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
    Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Varicella zoster reactivation after hematopoietic stem cell transplant in children is strongly correlated with leukemia treatment and suppression of host T-lymphocyte immunity.
    Vermont CL; Jol-van der Zijde EC; Hissink Muller P; Ball LM; Bredius RG; Vossen AC; Lankester AC
    Transpl Infect Dis; 2014 Apr; 16(2):188-94. PubMed ID: 24438482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source.
    Chevallier P; Hebia-Fellah I; Planche L; Guillaume T; Bressolette-Bodin C; Coste-Burel M; Rialland F; Mohty M; Imbert-Marcille BM
    Bone Marrow Transplant; 2010 Jul; 45(7):1204-11. PubMed ID: 19935727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro expansion of polyclonal T-cell subsets for adoptive immunotherapy by recombinant modified vaccinia Ankara.
    La Rosa C; Wang Z; Lacey SF; Lalimarmo MM; Krishnan A; Longmate J; Diamond DJ
    Exp Hematol; 2006 Apr; 34(4):497-507. PubMed ID: 16569596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterizing human herpes virus 6 following hematopoietic stem cell transplantation.
    Perissinotti AJ; Gulbis A; Shpall EJ; Howell J
    J Oncol Pharm Pract; 2015 Apr; 21(2):85-92. PubMed ID: 24407957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between the detection of viral DNA by the polymerase chain reaction in peripheral blood leukocytes and serological responses to human herpesvirus 6, human herpesvirus 7, and cytomegalovirus in renal allograft recipients.
    Osman HK; Peiris JS; Taylor CE; Karlberg JP; Madeley CR
    J Med Virol; 1997 Nov; 53(3):288-94. PubMed ID: 9365898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus (EBV) reactivation in allogeneic stem-cell transplantation: relationship between viral load, EBV-specific T-cell reconstitution and rituximab therapy.
    Clave E; Agbalika F; Bajzik V; Peffault de Latour R; Trillard M; Rabian C; Scieux C; Devergie A; Socié G; Ribaud P; Adès L; Ferry C; Gluckman E; Charron D; Esperou H; Toubert A; Moins-Teisserenc H
    Transplantation; 2004 Jan; 77(1):76-84. PubMed ID: 14724439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pre-transplant cytomegalovirus (CMV) serostatus remains the most important determinant of CMV reactivation after allogeneic hematopoietic stem cell transplantation in the era of surveillance and preemptive therapy.
    George B; Pati N; Gilroy N; Ratnamohan M; Huang G; Kerridge I; Hertzberg M; Gottlieb D; Bradstock K
    Transpl Infect Dis; 2010 Aug; 12(4):322-9. PubMed ID: 20487414
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical CD4
    Russell SJ; Duran J; Fuchs D; Yeager AM
    Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):531-535. PubMed ID: 31053550
    [No Abstract]   [Full Text] [Related]  

  • 39. Human herpesvirus type 6 reactivation after haematopoietic stem cell transplantation.
    de Pagter PJ; Schuurman R; Meijer E; van Baarle D; Sanders EA; Boelens JJ
    J Clin Virol; 2008 Dec; 43(4):361-6. PubMed ID: 18829379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.